Quick Answer
Corbus Pharmaceuticals Holdings, Inc. reported Total Assets of $168.19 million for fiscal year 2025.
Corbus Pharmaceuticals Holdings, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $168.19M | +7.9% |
| 2024 | $155.88M | +451.4% |
| 2023 | $28.27M | -57.4% |
| 2022 | $66.31M | -38.4% |
| 2021 | $107.73M | +5.3% |
| 2020 | $102.29M | +108.2% |
| 2019 | $49.14M | +4.6% |
| 2018 | $46.99M | -29.8% |
| 2017 | $66.98M | +274.4% |
| 2016 | $17.89M | +38.9% |
| 2015 | $12.88M | +95.1% |
| 2014 | $6.60M | +2060.5% |
| 2013 | $305.5K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $109.51M | -33.3% | -12.4% |
| June 30, 2025 | $125.08M | -17.7% | -10.6% |
| March 31, 2025 | $139.93M | +11.3% | -10.2% |
| December 31, 2024 | $155.88M | +451.4% | -5.1% |
| September 30, 2024 | $164.17M | +352.5% | +8.0% |
| June 30, 2024 | $151.98M | +247.6% | +20.9% |
| March 31, 2024 | $125.74M | +143.5% | +344.8% |
| December 31, 2023 | $28.27M | -57.4% | -22.1% |
- Corbus Pharmaceuticals Holdings, Inc. showed an increase of +7.9% in Total Assets compared to the prior fiscal year.
- Over the 2013–2025 period, Corbus Pharmaceuticals Holdings, Inc.’s total assets has grown by 54952.0% (from $305.5 thousand to $168.19 million).
- The most recent figure is from Corbus Pharmaceuticals Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: